Dr. Lal PathLabs IPO GMP History
Dr. Lal PathLabs IPO has been listed on December 23, 2015 at a listing price of ₹720, against the issue price of ₹550 — a gain of ₹170 (+30.91%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Dr. Lal PathLabs IPO raised ₹631.91 Cr. through its IPO at a price band of ₹540 to ₹550 per share, with a lot size of 20 shares. The IPO was open for subscription from 08 Dec 2015 to 10 Dec 2015.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 12 Nov, 3:10 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
Dr. Lal PathLabs IPO dates
Key dates from opening to listing. Today is 15 November.
- Open 08 Dec 2015
- Close 10 Dec 2015
- Allotment 19 Dec 2015
- Refund/credit TBA
- Listing 23 Dec 2015
Dr. Lal PathLabs IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹550 |
|---|---|
| Listing gain / loss | +₹170 per share |
| Listing date | 23 Dec, 2015 |
| Actual listing price | ₹720 (+30.91%) |
Is Dr. Lal PathLabs IPO GMP reliable?
Grey market premium for Dr. Lal PathLabs IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Dr. Lal PathLabs IPO full review for a fundamentals-based assessment before making any grey market trades.
Dr. Lal PathLabs IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Dr. Lal PathLabs IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Dr. Lal PathLabs IPO
Dr. Lal PathLabs Limited is a Delhi based provider of diagnostic and related healthcare tests and services. Its promoters are Arvind Lal, Vandana Lal and Eskay House.
Through its nationwide network it offers patients and healthcare providers a broad range of diagnostic tests for core testing, patient diagnosis and the prevention, monitoring and treatment of disease.
It has built a national network of laboratories and patient service centres.
The IPO was Rs 631.91 crore and was entirely an offer for sale at Rs 550, the top of the Rs 540 to Rs 550 band, so the company received no money.
Frequently asked
What is the GMP of Dr. Lal PathLabs IPO?
The current Grey Market Premium (GMP) of Dr. Lal PathLabs IPO is not yet started or active in the market.
What is the Kostak Price of Dr. Lal PathLabs IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Dr. Lal PathLabs IPO is not available.
What is the Subject to Sauda Price of Dr. Lal PathLabs IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Dr. Lal PathLabs IPO?
Dr. Lal PathLabs IPO listed on December 23, 2015 at ₹720, against the issue price of ₹550 — a gain of +30.91%.
How did the GMP of Dr. Lal PathLabs IPO trend before listing?
The GMP of Dr. Lal PathLabs IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore Dr. Lal PathLabs IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
